Procalcitonin and C-reactive protein in infective endocarditis:: Correlation with etiology and prognosis

被引:48
|
作者
Kocazeybek, B [1 ]
Küçükoglu, S
Öner, YA
机构
[1] Istanbul Univ, Cerrahpasa Med Fac, Dept Microbiol & Clin Microbiol, TR-34303 Cerrahpasa, Turkey
[2] Istanbul Univ, Dept Cardiol, Cardiol Inst, Istanbul Fac Med, TR-34303 Cerrahpasa, Turkey
[3] Istanbul Univ, Dept Microbiol & Clin Microbiol, Istanbul Fac Med, TR-34303 Cerrahpasa, Turkey
关键词
infective endocarditis; procalcitonin; C-reactive protein;
D O I
10.1159/000069777
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The aim of this study was to investigate the diagnostic values of serum procalcitonin (PCT) and C-reactive protein (CRP) levels in infective endocarditis (IE) and to correlate them with the etiology of the disease and the prognosis of the patients. Methods: Fifty patients who were diagnosed as having IE based on Duke criteria (major and/or minor) were included in the study at the Istanbul University Cardiology Institute and Florence Nightingale Hospital. Forty patients with bacteremia (non-IE) and 50 healthy blood donors were also included in the study as the control group. During the 45 days of medical follow-up, in those patients who had a response to medical therapy based on the results of left ventricular function tests, transesophageal echocardiography (TEE) and culture, among other factors, PCT and CRP levels were measured in 5-cm(3) blood samples obtained without anticoagulant when they were first admitted (day 0), as well as 24 h and 15, 30 and 45 days after admission. In the patients who had valve replacement, 5-cm(3) blood samples without anticoagulant were similarly obtained on the day of admission, after 24 h and/or on the 15th day, and 1 day before and on the 2nd and 5th days after the operation. Results: In this study, a significant difference (p < 0.001) was found between the IE group and the healthy control group with respect to their serum PCT and CRP levels at the time of admission. No significant difference was found between IE and non-IE groups (p > 0.05). The sensitivity of PCT in comparison to CRP was found to be lower (84 vs. 100%); however, its specificity was determined to be higher (88 vs. 72%). The median values of serum PCT in the nonoperated and operated cases at the time of admission, after 24 h and on the 15th day were 3.71, 5.35 and 0.44, and 2.45, 4.28 and 4.22 ng/ml, respectively, and those of CRP were 9.30, 10.95 and 10.65, and 9.5, 10.9 and 10.2 mg/dl, respectively. The median values of serum PCT were found to be higher in cases with IE and non-IE related to gram-negative bacteria than those related to gram-positive bacteria (p < 0.02). This was found to be insignificant for CRP (p > 0.05). Conclusions: As a result, this study suggests that in the diagnosis of IE, it would be beneficial to use PCT, besides TEE, culture and other clinical criteria, for its high specificity and positive predictive value in comparison to CRP. This study also suggests that in determining the response to medical treatment in the follow-up period, PCT could be a more valuable parameter than CRP, as PCT has a high prognostic value and is a good indicator for valve replacement in addition to the major criteria. Furthermore, serum PCT levels may help the physician to decide on the antimicrobial therapy combination before obtaining the culture results, or in situations in which the agent could not be isolated yet. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:76 / 84
页数:9
相关论文
共 50 条
  • [21] Procalcitonin, C-Reactive Protein, and Neutrophil Ratio Contribute to the Diagnosis and Prognosis of Severe Acute Pancreatitis
    Liang, Yi
    Zhao, Xianwei
    Meng, Fanliang
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2019, 48 (12) : 2177 - 2186
  • [22] C-REACTIVE PROTEIN, RHEUMATOID FACTOR AND CIRCULATORY IMMUNE COMPLEX AS MARKERS FOR MONITORING TREATMENT OF INFECTIVE ENDOCARDITIS
    Alavi, Seyed Mohammad
    Ahmadi, Fatemeh
    Nashibi, Rouhangiz
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2009, 25 (05) : 825 - 828
  • [23] Prognostic value of the C-reactive protein-to-albumin ratio in patients with infective endocarditis
    Baykiz, D.
    Govdeli, E. A.
    Demirtakan, Z. G.
    Elitok, A.
    Umman, B.
    Bugra, Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (23) : 8728 - 8737
  • [24] Kinetics of C-reactive protein and procalcitonin after scoliosis surgery
    Sariego, A.
    Rey, C.
    Medina, A.
    Los-Arcos, M.
    Concha, A.
    Gonzalez, M.
    BOLETIN DE PEDIATRIA, 2012, 52 (219): : 19 - 22
  • [25] Procalcitonin and C-reactive protein as biomarkers for neonatal bacterial infection
    Quadir, Ashfaque F.
    Britton, Philip N.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2018, 54 (06) : 695 - 699
  • [26] Procalcitonin and C-reactive protein in differantiating to contamination from bacteremia
    Oksuz, Lutfiye
    Somer, Ayper
    Salman, Nuran
    Erk, Osman
    Gurler, Nezahat
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2014, 45 (04) : 1415 - 1421
  • [27] COMPARISON OF C-REACTIVE PROTEIN AND PROCALCITONIN IN THE DIAGNOSIS OF NEONATAL SEPSIS
    Topuz, Sadik
    Ovali, Fahri
    NOBEL MEDICUS, 2012, 8 (01): : 72 - 76
  • [28] The Utility of C-Reactive Protein, Procalcitonin, and Leukocyte Values in Predicting the Prognosis of Patients with Pneumosepsis and Septic Shock
    Doganci, Melek
    Doganay, Guler Eraslan
    Sazak, Hilal
    Alagoz, Ali
    Cirik, Mustafa Ozgur
    Hosgun, Derya
    Cakiroglu, Emine Banu
    Yildiz, Murat
    Ari, Maside
    Ozdemir, Tarkan
    Kizilgoz, Derya
    MEDICINA-LITHUANIA, 2024, 60 (10):
  • [29] Contested role of procalcitonin and C-reactive protein in the diagnosis of fascioliasis
    Cakir, Fatih
    Bilden, Alican
    Ozcan, Nida
    Cicek, Mutalip
    PARASITOLOGISTS UNITED JOURNAL, 2022, 15 (01) : 117 - 120
  • [30] Accuracy and Prognosis Value of the Sequential Organ Failure Assessment Score Combined With C-Reactive Protein in Patients With Complicated Infective Endocarditis
    Lin, Yaowang
    Dong, Shaohong
    Yuan, Jie
    Yu, Danqing
    Bei, Weijie
    Chen, Ruimian
    Qin, Haiyan
    FRONTIERS IN MEDICINE, 2021, 8